Comment

Biometrical Journal

Volumn 47, Issue 2, 2005, Pages 133-135

  Senn, Stephen ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 17844381055     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200510109     Document Type: Article

References (18)

1. Anonymous. (2003). Gulf war syndrome doctor faked £90m trial for diabetic drug British Nursing News Online. http://www.bnn-online.co.uk/ comments_display.asp?HeadlineID=36531 & Year=2003.
2. Benveniste, J. (1988). Benveniste on Nature investigation. Science 241, 4869, 1028.
3. Berger, V. (2005). Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials. Biometrical Journal 47, 119-127.
4. Berger, V. W. and Exner, D. V. (1999). Detecting selection bias in randomized clinical trials. Controlled Clinical Trials 20, 4, 319-327.
5. Day, S., Payers, P., and Harvey, D. (1998). Double data entry: what value, what price? Controlled Clinical Trials 19, 1, 15-24.
6. Degroot, M. (1986). A conversation with Persi Diaconis. Statistical Science 1, 319-334.
7. Dyer, O. (2003). CMC reprimands doctor for research fraud. British Medical Journal 326, 7392, 730.
8. Earman, J. (2002). Bayes's Theorem, Miracles and Theism. Bayes's Theorem, R. Swinburne (ed.). Oxford University Press, Oxford.
9. Farthing, M. J. G. (2004). 'Publish and be damned'... the road to research misconduct. The Journal of the Royal College of Physicians of Edinburgh 34, 301-304.
10. Fergusson, D., Glass, K. C., Waring, D., and Shapiro, S. (2004). Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials. British Medical Journal 328, 7437, 432.
11. Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., Karlberg, B. E., Wester, P. O., and Björk, J. E. (1999). Effect of angiotensin-converting-enzyme inhibition compared with conventional morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 353, 611-616.
12. Maddox, J., Randi, J., and Stewart, W. W. (1988). "High- dilution" experiments a delusion. Nature 334, 6180, 287-290.
13. Peto, R. (1999). Failure of randomisation by "sealed" envelope. Lancet 354, 9172, 73.
14. Philipson, T. and Desimone, J. (1997). Experiments and subject sampling. Biometrika 84, 3, 619-630.
15. Senn, S. J. (1993). Inherent difficulties with active control equivalence studies. Statistics in Medicine 12, 2367-2376.
16. Senn, S. J. (1994a). Fisher's game with the devil. Statistics in Medicine 13, 217-230.
17. Senn, S. J. (1994b). Testing for baseline balance in clinical trials. Statistics in Medicine 13, 1715-1726.
18. Senn, S. J. (2004). Turning a blind eye: Authors have blinkered view of blinding. British Medical Journal 328, 7448, 1135-1136.